Myers, Daniel – Trademark Portfolio

Entity Type: 01

Myers, Daniel holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 2 filings in this category. The portfolio also extends into Class 41 (Education & Entertainment) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include RX FOR EX. The owner is based in Niverville, NY.

P.O. Box 245

Niverville, NY 12130

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Myers, Daniel's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

42
Computer & Scientific (2 filings)

Scientific and technological services; industrial analysis and research services

41
Education & Entertainment (1 filing)

Education; providing of training; entertainment; sporting and cultural activities

15
Musical Instruments (1 filing)

Musical instruments

Frequently Asked Questions

How many trademarks does Myers, Daniel have?

Myers, Daniel has 4 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned, 2 cancelled.

What trademark classes does Myers, Daniel file in?

Myers, Daniel files trademarks across 3 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 41 (Education & Entertainment), Class 15 (Musical Instruments). Class 42 covers scientific and technological services; industrial analysis and research services.

What are Myers, Daniel's most well-known trademarks?

Myers, Daniel's registered trademark portfolio includes well-known marks such as RX FOR EX. These are among 1 currently registered trademark in the portfolio.

What is Myers, Daniel's trademark registration success rate?

Myers, Daniel has a 25% trademark registration rate, with 1 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.